Cargando…
Targeting interleukin-17 in chronic inflammatory disease: A clinical perspective
Chronic inflammatory diseases like psoriasis, Crohn’s disease (CD), multiple sclerosis (MS), rheumatoid arthritis (RA), and others are increasingly recognized as disease entities, where dysregulated cytokines contribute substantially to tissue-specific inflammation. A dysregulation in the IL-23/IL-1...
Autores principales: | Zwicky, Pascale, Unger, Susanne, Becher, Burkhard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037236/ https://www.ncbi.nlm.nih.gov/pubmed/31727781 http://dx.doi.org/10.1084/jem.20191123 |
Ejemplares similares
-
Interleukin-17 in Chronic Inflammatory Neurological Diseases
por: Milovanovic, Jelena, et al.
Publicado: (2020) -
Interleukin-17 in human inflammatory diseases
por: Shabgah, Arezoo Gowhari, et al.
Publicado: (2014) -
Current perspective on the role of the interleukin-23/interleukin-17 axis in inflammation and disease (chronic arthritis and psoriasis)
por: Cauli, Alberto, et al.
Publicado: (2015) -
Interleukin-17: Potential Target for Chronic Wounds
por: Hadian, Yasmin, et al.
Publicado: (2019) -
Interleukin‐17‐producing γδ T (γδ17) cells in inflammatory diseases
por: Akitsu, Aoi, et al.
Publicado: (2018)